Mimedx (MDXG) Net Cash Flow (QoQ) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Mimedx | 530.69 Mn | 370.92 Mn | 41.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -126.41% |
| Dec 31, 2025 | 3.55% |
| Sep 30, 2025 | 86.64% |
| Jun 30, 2025 | 517.27% |
| Mar 31, 2025 | -87.82% |
| Dec 31, 2024 | -12.15% |
| Sep 30, 2024 | -12.32% |
| Jun 30, 2024 | 164.09% |
| Mar 31, 2024 | -4,108.73% |
| Dec 31, 2023 | -93.32% |
| Sep 30, 2023 | 68.38% |
| Jun 30, 2023 | 257.14% |
| Mar 31, 2023 | -278.18% |
| Dec 31, 2022 | 271.19% |
| Sep 30, 2022 | 122.53% |
| Jun 30, 2022 | 72.17% |
| Mar 31, 2022 | 0.08% |
| Dec 31, 2021 | -303.86% |
| Sep 30, 2021 | 2,045.59% |
| Jun 30, 2021 | 102.36% |
| Mar 31, 2021 | 19.71% |
| Dec 31, 2020 | -122.45% |
| Sep 30, 2020 | 1,250.79% |
| Jun 30, 2020 | 65.67% |
| Mar 31, 2020 | 37.96% |
| Dec 31, 2019 | -792.52% |
| Sep 30, 2019 | -104.09% |
| Jun 30, 2019 | 509.56% |
| Mar 31, 2019 | -26,666.67% |
| Dec 31, 2018 | -91.25% |
| Sep 30, 2018 | -95.97% |
| Jun 30, 2018 | 1,849.61% |
| Mar 31, 2018 | 79.46% |
| Dec 31, 2017 | 54.81% |
| Sep 30, 2017 | -166.30% |
| Jun 30, 2017 | 579.06% |
| Mar 31, 2017 | -124.47% |
| Dec 31, 2016 | 359.25% |
| Sep 30, 2016 | -162.92% |
| Jun 30, 2016 | 164.97% |
| Mar 31, 2016 | -6.21% |
| Dec 31, 2015 | -609.18% |
| Sep 30, 2015 | 2,702.11% |
| Jun 30, 2015 | 98.80% |
| Mar 31, 2015 | -1,077.01% |
| Dec 31, 2014 | -108.37% |
| Sep 30, 2014 | 312.16% |
| Jun 30, 2014 | -256.37% |
| Mar 31, 2014 | -102.79% |
| Dec 31, 2013 | 1,934.97% |
| Sep 30, 2013 | 221.98% |
| Jun 30, 2013 | -48.78% |
| Mar 31, 2013 | -18.61% |
| Dec 31, 2012 | -117.47% |
| Sep 30, 2012 | 1,454.86% |
| Jun 30, 2012 | 66.40% |
| Mar 31, 2012 | -131.40% |
| Dec 31, 2011 | 455.64% |
| Sep 30, 2011 | -264.56% |
| Jun 30, 2011 | 285.34% |